109 related articles for article (PubMed ID: 22509921)
21. Possible enhancement of BP180 autoantibody production by herpes zoster.
Kamiya K; Aoyama Y; Suzuki T; Niwa H; Horio A; Nishio E; Tokura Y
J Dermatol; 2016 Feb; 43(2):197-9. PubMed ID: 26212492
[TBL] [Abstract][Full Text] [Related]
22. Case of anti-laminin gamma-1 pemphigoid with antibody against C-terminal domain of BP180 in a patient with psoriasis vulgaris.
Ansai S; Hashizume S; Kawana S; Tateishi C; Koga H; Hashimoto T
J Dermatol; 2014 Nov; 41(11):1031-3. PubMed ID: 25294280
[No Abstract] [Full Text] [Related]
23. Bullous pemphigoid: What's ahead?
Furue M; Kadono T
J Dermatol; 2016 Mar; 43(3):237-40. PubMed ID: 26603373
[TBL] [Abstract][Full Text] [Related]
24. Case of subepidermal bullous disease with diffuse esophageal involvement presenting with immunoglobulin G autoantibodies to both the BP180 NC16a and C-terminal domains, and immunoglobulin A autoantibodies to the BP180 NC16a domain.
Takayama N; Nakazono S; Kumagai J; Kawamura T; Suzuki F; Ishii N; Hashimoto T; Namiki T
J Dermatol; 2014 Jul; 41(7):665-7. PubMed ID: 24930476
[No Abstract] [Full Text] [Related]
25. Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.
Kamiya K; Aoyama Y; Noda K; Miyake T; Yamaguchi M; Hamada T; Tokura Y; Iwatsuki K
J Dermatol Sci; 2015 Apr; 78(1):77-9. PubMed ID: 25771164
[No Abstract] [Full Text] [Related]
26. Collagen XVII/BP180 protein expression in squamous cell carcinoma of the skin detected with novel monoclonal antibodies in archived tissues using tissue microarrays and digital microscopy.
Stelkovics E; Korom I; Marczinovits I; Molnar J; Rasky K; Raso E; Ficsor L; Molnar B; Kopper L; Krenacs T
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):433-41. PubMed ID: 18633319
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients.
Di Zenzo G; Grosso F; Terracina M; Mariotti F; De Pità O; Owaribe K; Mastrogiacomo A; Sera F; Borradori L; Zambruno G
J Invest Dermatol; 2004 Jan; 122(1):103-10. PubMed ID: 14962097
[TBL] [Abstract][Full Text] [Related]
28. Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies.
Nishie W
Methods Mol Biol; 2013; 961():363-9. PubMed ID: 23325657
[TBL] [Abstract][Full Text] [Related]
29. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens.
Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T
J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421
[No Abstract] [Full Text] [Related]
30. Circulating IgE anti-BP180 autoantibody and its correlation to clinical and laboratorial aspects in bullous pemphigoid patients.
Ma L; Wang M; Wang X; Chen X; Zhu X
J Dermatol Sci; 2015 Apr; 78(1):76-7. PubMed ID: 25797173
[No Abstract] [Full Text] [Related]
31. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.
Nishie W
J Dermatol Sci; 2014 Mar; 73(3):179-86. PubMed ID: 24434029
[TBL] [Abstract][Full Text] [Related]
32. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
[TBL] [Abstract][Full Text] [Related]
33. BP180/Collagen XVII: A Molecular View.
Tuusa J; Kokkonen N; Tasanen K
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830116
[TBL] [Abstract][Full Text] [Related]
34. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC
J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314
[TBL] [Abstract][Full Text] [Related]
35. Collagen XVII: a shared antigen in neurodermatological interactions?
Seppänen A
Clin Dev Immunol; 2013; 2013():240570. PubMed ID: 23878581
[TBL] [Abstract][Full Text] [Related]
36. Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.
Wada N; Uchi H; Furue M
J Dermatol; 2017 Oct; 44(10):e240-e241. PubMed ID: 28677843
[No Abstract] [Full Text] [Related]
37. Bullous pemphigoid autoantibodies preferentially recognize phosphoepitopes in collagen XVII.
Zimina EP; Hofmann SC; Fritsch A; Kern JS; Sitaru C; Bruckner-Tuderman L
J Invest Dermatol; 2008 Nov; 128(11):2736-2739. PubMed ID: 18548115
[No Abstract] [Full Text] [Related]
38. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
[TBL] [Abstract][Full Text] [Related]
39. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.
Ujiie H; Shibaki A; Nishie W; Sawamura D; Wang G; Tateishi Y; Li Q; Moriuchi R; Qiao H; Nakamura H; Akiyama M; Shimizu H
J Immunol; 2010 Feb; 184(4):2166-74. PubMed ID: 20089696
[TBL] [Abstract][Full Text] [Related]
40. Type XVII collagen ELISA indices significantly decreased after bullous pemphigoid remission.
Kusajima E; Akiyama M; Sato M; Natsuga K; Shimizu H
Int J Dermatol; 2011 Feb; 50(2):238-40. PubMed ID: 21244398
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
